Telle 2015
Telle 2015
Telle 2015
Topical Review
Keywords: Classification, diagnosis, and treatment of hemorrhage into the anterior chamber of the eye, or hyphema,
hyphema
can be a challenging and frustrating process for many practitioners, especially in emergency situations.
emergency
This review outlines an inclusive list of causes, diagnostics, and treatments for traumatic and
canine
feline nontraumatic hyphema in both canine and feline patients. The review is tailored to small animal
hemorrhage practitioners, especially in emergency practice, and is designed to provide concise but thorough
bleeding descriptions on investigating underlying causes of hyphema and treating accordingly.
Published by Elsevier Inc.
a
Small Animal Clinical Sciences, College of
Veterinary Medicine, University of Tennessee
Veterinary Medical Center, Knoxville, TN, USA
b
Department of Clinical Sciences, College of
Veterinary Medicine, Mississippi State
University, Mississippi State, MS, USA
n
Address reprint requests to: Caroline
Betbeze, DVM, MS, Dipl. ACVO, Department
of Clinical Sciences, College of Veterinary
Medicine, Mississippi State University, PO
Box 6100, Mississippi State, MS 39762, USA.
E-mail: [email protected]
(C. Betbeze)
Blunt force head trauma and penetrating eye wounds are some Coagulopathies and Bleeding Disorders
of the most common veterinary emergencies, typically caused by
vehicular accidents and animal fights. These patients may present Systemic bleeding disorders commonly responsible for causing
with severe clinical signs such as skull fractures or inappropriate hyphema include thrombocytopenia, hemolytic and nonhemo-
mentation or more inconspicuous clinical signs, such as hyphema. lytic anemia, and clotting disorders. Although inherited coagulo-
Protection by the bony orbit and soft tissues surrounding the eye pathies are seen infrequently in emergency situations, acquired
http://dx.doi.org/10.1053/j.tcam.2015.07.008
1527-3369/ & 2015 Topics in Companion Animal Medicine. Published by Elsevier Inc.
98 M.R. Telle, C. Betbeze / Topics in Companion An Med 30 (2015) 97–106
Fig. 5. Hyphema present in association with multicentric lymphoma and anterior Fig. 6. This is the same patient as seen in Fig 5. All palpable lymph nodes were
uveitis in a 6-year-old pit bull terrier. Aqueous flare with a small amount of enlarged and firm.
hyphema is present in both eyes.
RMSF should also be considered in dogs with hyphema, subcon- Collie eye anomaly is an inherited disorder described in both
junctival hemorrhage, anterior uveitis, and inflammatory cell infil- rough and smooth collies that involves incomplete development
trates, especially in endemic areas.27 Additionally, these dogs may of the choroid, defects of the optic nerve, retinal detachment, or
not be on flea and tick prevention, as it is a tick-borne disease thinning of the sclera. This condition is recessively inherited and
caused by Rickettsia rickettsia, which is transmitted by the American there are genetic tests available for breeders and buyers.1,4 Retinal
dog tick (Dermacentor variabilis), Rocky Mountain wood tick detachment is a common sequelae to these changes and subse-
(Dermacentor andersoni), and the brown dog tick (Rhipicephalus quently leads to hyphema in most of these instances.
sanguineus).28 Other common clinical signs appreciated in dogs with Vitreoretinal dysplasia has also been associated with retinal
RMSF include fever, lethargy, ecchymoses, and retinal hemor- detachment, which then leads to hemorrhage into the anterior
rhages.28 Diagnosis can be made by assessing titers, which may take chamber. This condition has been described in several breeds,
a considerable amount of time, so if suspected, treatment may be including Labrador retrievers, Bedlington terriers, Springer span-
warranted before definitive diagnosis, especially in endemic areas.28 iels, and Sealyham terriers. Puppies of the aforementioned breeds
should be considered especially susceptible to this condition and
Systemic Hypertension should be thoroughly examined for the deformities when
hyphema is present. Glaucoma is a common result of hyphema
Hypertensive retinopathy is the most common ocular clinical in these cases.1,4
sign associated with systemic hypertension, but hyphema may During embryonic development of the eye, the hyaloid artery is
also be a presenting sign with this disease. Because of the the primary arterial blood supplier providing nutrients to the lens
autoregulation of the vasculature of the eyes, central nervous and retina.32 Failure of this artery to regress normally results in a
system, heart, and kidneys, these organs are known as end persistent hyaloid artery. The persistence of this vascular structure
organs29 and are commonly associated with significant damage can lead to rupture and result in bleeding into the lens, the
from systemic hypertension.29,30 vitreous, and anterior chamber, resulting in hyphema.4,32
Because the choroid and retina are extremely vascular, these
structures respond to systemic hypertension by arteriolar vaso- Retinal Detachment
constriction, thus leading to disruption of the integrity of the
vasculature and increased vascular permeability due to arterial Retinal detachments can be described either as primary or as
endothelial cell damage.30 This vascular permeability can lead to secondary in small animal patients. Secondary retinal detach-
retinal hemorrhage, edema, retinal detachment, secondary glau- ments caused by infectious diseases, inflammation, neoplasia,
coma, and hyphema.30 systemic hypertension, and congenital abnormalities are far more
Essential (primary) systemic hypertension tends to be rare in common than primary retinal detachments, which are rare in
dogs and cats; therefore, several underlying disease processes veterinary medicine.2,4
should be investigated when systemic hypertension is sus- Subretinal or intraretinal edema is a common mechanism of
pected.30,31 Some of the most common underlying etiologies retinal detachment and may result from a number of causes.2 Any
causing systemic hypertension in both dogs and cats include renal cause of retinal detachment can lead to hemorrhage due to
failure (acute and chronic), protein-losing nephropathies, hyper- damage of retinal vasculature.2 Common causes of retinal detach-
thyroidism (cats), hyperadrenocorticism, pheochromocytoma, and ment in dogs and cats are associated with systemic diseases
diabetes mellitus.30,31 Assessing blood pressure of all patients (nonrhegmatogenous)4,33 or with a retinal hole or tear (rhegma-
presenting with hyphema is extremely important, especially if togenous).33 Both types of detachment can be associated with
one of the underlying disease processes is present (Fig 7). intraocular hemorrhage.2
Retinal detachments can also be caused by trauma, and they
are commonly seen in animals that have suffered blunt force
Congenital Anomalies
trauma to the head or to the globe. Penetrating trauma can also
cause retinal detachment.33 Because these incidents can cause
A congenital ocular disorder should be suspected in young
direct detachment of the retina, the retinal vessels may become
animals presenting with hyphema with no known traumatic
leaky and bleed directly into the vitreous or anterior chamber
cause. Disorders to consider include Collie eye anomaly, persistent
traveling anteriorly, which may manifest as hyphema. This is a
hyaloid artery, and vitreoretinal dysplasia.1,4
particularly important cause of hyphema in the small animal
patient, especially in emergency situations.
Anterior Uveitis
Diagnostics
History
Ophthalmic Examination
Diagnostic Imaging
Fig. 11. A complete physical and ophthalmic examination is necessary in all cases
When investigating systemic diseases, thoracic and abdominal
of hyphema. Serial tonometry is especially important to monitor for glaucoma imaging can be extremely useful. Because neoplasia, infectious
development. diseases, and fungal diseases (as discussed previously) are
M.R. Telle, C. Betbeze / Topics in Companion An Med 30 (2015) 97–106 103
Table 1
Etiologies of Hyphema
Trauma
Blunt force trauma
Penetrating eye wounds
Vehicular trauma and animal fights
Proptosis
Gunshot wounds
Coagulopathies
Acquired (i.e., rodenticide intoxication, thrombocytopenia,
immune-mediated, DIC, drug toxicity, and infection)
Inherited or congenital
Bleeding disorders
Thrombocytopenia
Anemia
Drug induced
Infectious agents (i.e., ehrlichiosis, FeLV, and FIV)
Neoplasia
Neoplasia
Fig. 12. B-mode ocular ultrasound with a 12-MHz probe. Note the hyphema in Primary (i.e., ocular melanoma and adenoma)
anterior chamber and classical seagull sign of retinal detachment in this 4-year-old Secondary (i.e., lymphoma, hemangiosarcoma, multiple myeloma,
boxer with lymphoma. and transmissible venereal tumor)
Infectious diseases
Tick borne (i.e., Rocky Mountain spotted fever and ehrlichiosis)
common causes of hyphema, abdominal ultrasound and thoracic Bacterial (i.e., brucellosis and leptospirosis)
radiographs are recommended in any patient without an obvious Fungal (i.e., aspergillosis)
cause of hyphema. Thoracic radiographs may reveal primary or Other (i.e., protothecosis)
metastatic disease, evidence of pulmonary, pericardial, or pleural Systemic hypertension
hemorrhage and can change the therapy and possibly worsen the Renal failure
prognosis for the patient. Abdominal ultrasound may reveal fluid or Protein-losing nephropathy
blood in the abdomen or abnormalities in the abdominal organs. Hyperthyroidism
Hyperadrenocorticism
Perhaps one of the most useful diagnostic imaging tools for Pheochromocytoma
patients with hyphema is the use of B-mode real-time ocular Diabetes mellitus
ultrasonography.2 This imaging can assist in diagnosing intra-
Congenital anomalies
ocular masses, intraocular hemorrhage, and retinal detachments, Collie eye anomaly
especially when visualization of the intraocular structures is Persistent hyaloid artery
compromised by injury or hyphema in the eye2,5 (Fig 12). This Vitreoretinal dysplasia
practice can assist in giving a more accurate prognosis for vision Retinal detachment
and comfort in the affected eye. Most of the time, ocular ultra- Primary
sonography is performed by a board-certified ophthalmologist or Secondary (i.e., trauma, infectious diseases, inflammation,
neoplasia, systemic hypertension, and congenital anomalies)
radiologist and a topical anesthetic should be applied to the
affected cornea before performing the ultrasound.5 Anterior uveitis
Neoplasia
Further diagnostic imaging including computed tomography
Immune-mediated
with or without contrast or magnetic resonance imaging may be Infectious disease
warranted when more serious involvement of structures of the
Chronic glaucoma
head, neck, or central nervous system are suspected; however,
these imaging modalities usually require a referral institution and DIC, disseminated intravascular coagulation.
a significant monetary commitment and should be thoroughly
discussed with the owner.1 Skull radiographs may be helpful in
identifying orbital fractures or other abnormalities in the skull1 segment.1 Careful attention should be paid to the integrity of the
(Table 1). cornea before using these medications because corticosteroids
may be contraindicated when corneal abrasions, penetrating
wounds, or corneal ulcers are present.1 It is common to have
Treatment some hyphema associated with penetrating trauma to the cornea
and the clinician must weigh the need for anti-inflammatory
Therapy for hyphema in the small animal patient should medication against the severity of the corneal injury because
always include treatment of the underlying disease and associated corticosteroids may delay healing. Systemic corticosteroids such
conditions. For treatment of the eye with hyphema, however, as prednisone may also be used to prevent reoccurrence of
empirical treatments with topical corticosteroids and mydriatics hemorrhage if they are not contraindicated in a patient.1,2,5,43
are usually instituted immediately. If the blood or fibrin is clotted, Although nonsteroidal anti-inflammatory drugs are commonly
intracameral injection of tissue-plasminogen activator (TPA) or used to treat uveitis to decrease inflammation, nonsteroidal anti-
systemic aminocaproic acid could be instituted.1,2,5,36,42 inflammatory drugs are generally avoided when treating hyphema
Topical corticosteroids are used to prevent bleeding from because they interfere with platelet function and may actually
reoccurring by inhibiting fibrinolysis and reestablishing the cause more bleeding to occur.1,5,36,43
blood-ocular barrier.42,43 The most commonly used topical corti- Topical parasympatholytics (i.e., 1% atropine) are used to
costeroids are dexamethasone sodium phosphate and predniso- prevent formation of posterior synechiae and iris bombe, to
lone acetate, as both of these medications have the ability to stabilize the blood-aqueous barrier, and decrease ciliary body
penetrate the intact cornea and act directly on the anterior spasm.1,2,5,36,42 Topical administration of atropine 2-3 times a
104 M.R. Telle, C. Betbeze / Topics in Companion An Med 30 (2015) 97–106
Fig. 13. (A) Hyphema and fibrin 5 days after initial medical therapy for uveitis was instituted. (B) Intracameral injection of tissue-plasminogen activator (TPA) (250 mg/mL)
into the anterior chamber. At this time, there was no active bleeding into the eye and the blood clot was still present. The hyphema completely resolved 12 hours after
injection.
day is recommended for initial therapy, but once dilation of the structures has occurred during the process. In general, animals
pupil has occurred, the frequency of administration should be with retinal disease including retinal detachment or vitreal,
reduced to avoid increased IOP and potential development of choroidal, or retinal hemorrhages have a grave to poor prognosis
glaucoma.1,5,36 It is important to serially check IOP during the for vision.1,2,36 In cases of uncomplicated hyphema with small
management of hyphema.1 If increased IOP is noted, atropine volumes of blood, the condition may take up to 1 week to
should be discontinued and glaucoma treatment should be started disappear; however, if the hyphema persists or recurs, further
immediately.1,36,43 diagnostics should be performed to investigate another possible
Parasympathomimetics such as pilocarpine have been used for underlying diagnosis. Enucleation should be performed in animals
treatment of hyphema36 in the past because of their ability to when neoplasia is of primary concern; however, further diagnos-
assist with blood removal through the trabecular meshwork and tics such as thoracic and abdominal radiographs should be
enhance fibinolysin activity.1 However, the use of this drug class in performed to look for metastasis. When metastasis is noted, the
the treatment of hyphema has become increasingly more con- prognosis is worse, although enucleation may still provide some
troversial because it is a miotic, which may increase the chance of comfort and palliative treatment for the patient.1,2,36 Animals with
posterior synechiae formation and iris bombe. This medication chronic hyphema usually suffer from secondary complications
also induces anterior uveitis, which is commonly already present such as glaucoma, and the prognosis for vision is usually poor.1
in cases of hyphema.1,18,36,43 In patients with smaller amounts of hyphema that do not have
In acute cases presenting within 72 hours of clot formation, an significantly increased IOP, treatment should be implemented and
injection of TPA can lead to quick resolution of the clot1,44 (Fig 13). prognosis should be reassessed when the hyphema has resolved
TPA is a synthetic fibrinolytic agent that is known to promote and an accurate assessment of the integrity of the intraocular
fibrinolysis in the anterior chamber of human and animal eyes.44 structures can be made.1,36 These patients have the best prognosis
Although the use of TPA in the treatment of hyphema is some- for vision.
times viewed as controversial, a 1992 study revealed substantial
fibrinolysis when TPA was injected intracamerally.44 TPA is most
effective within 72 hours of clot formation, but has been noted to Conclusion
be effective for up to a week after clot formation. It is indicated
only if recurrence of bleeding is unlikely.1,5,36,45 Topical and Hyphema is a common ocular abnormality seen in small
systemic fibrinolytics are commonly used in humans experiencing animal practice, especially in emergency cases. Several underlying
hyphema because they are known to prevent recurrent bleed- diseases are commonly associated with intraocular hemorrhage,
ing.1,5,46 E-aminocaproic acid, another fibrinolytic agent, is known including trauma, neoplasia, infectious disease, bleeding abnor-
to interfere with the conversion of plasminogen to plasmin.47 A malities, congenital abnormalities, retinal detachment, systemic
1974 study demonstrated that hyphema disappeared in the dog hypertension, and anterior uveitis. Because these etiologies are
eyes injected with E-aminocaproic acid46; however, this therapy is complex and very different, obtaining a detailed history and
not regularly used in veterinary medicine mostly because of cost, performing a thorough physical and ocular examination are
difficult administration schedule, and significant side effects.5 essential to determine the most likely cause of the hyphema.
As previously discussed, significant sequelae such as secondary Additional diagnostic testings including CBC, serum chemistry,
glaucoma and cataracts can develop from hyphema. If these urinalysis, coagulation panel, radiography, and ultrasonography
conditions develop, the prognosis for vision and healing is poor are helpful in determining an underlying cause and giving an
and enucleation may be considered as a final treatment option36 accurate prognosis for vision and comfort. A full ophthalmic
(Table 2). examination including tonometry and fluorescein staining should
be performed before starting the therapy. The most common
empirical therapy includes topical or systemic corticosteroids
Prognosis and mydriatics. Additional treatments with TPA and aminocaproic
acid have also been described in particular cases. Protecting the
Prognosis for hyphema greatly depends on the underlying eye from sequelae, specifically glaucoma or chronic uveitis, is a
cause of the bleeding and how much damage to the intraocular vital part of treatment to decrease discomfort and preserve vision.
M.R. Telle, C. Betbeze / Topics in Companion An Med 30 (2015) 97–106 105
Table 2
Treatment of Hyphema
Drug class and names Disorder and use Dose and frequency
Topical corticosteroids Uveitis or inflammation 1 Drop in affected eye(s) 4-6 times daily
Prednisolone acetate
suspension 1%
Dexamethasone
solution 0.1%
Topical parasympatholytics Uveitis or inflammation 1 Drop in affected eye(s) 2-3 times daily
Atropine 1% Used for the prevention of posterior synechiae Frequency should be reduced once dilation of pupil has occurred to prevent
and iris bombe development of glaucoma
Stabilize blood-aqueous barrier
Decreased ciliary body spasms
Topical NSAIDs Uveitis or inflammation 1 Drop in affected eye(s) 3-4 times daily
(controversial)
Flurbiprofen 0.03% Use of topical and systemic NSAIDs is controversial because they may interfere
Diclofenac 0.1% with platelet function
Aspirin:
Dogs: 10-15 mg/kg PO every 8-12 hours
Cats: 10 mg/kg PO every 48-72 hours
Robenacoxib:
Cats: 1 mg/kg PO once daily for 3 days
If an underlying cause or systemic illness is found during diag- 6. Book BP, van der Woerdt A, Wilkie DA. Ultrasonographic abnormalities in eyes
nosis, treatment of that underlying disease is crucial for the overall with traumatic hyphema obscuring intraocular structures: 33 cases (1991-
health of the patient. 2002). J Vet Emerg Crit Care 18:383–387, 2008
7. Gilger BC, Hamilton HL, Wilkie DA, van der Woerdt A, McLaughlin SA, Whitley
RD. Traumatic ocular proptoses in dogs and cats: 84 cases (1980-1993). J Am Vet
Med Assoc 206:1186–1190, 1995
Acknowledgments 8. Couto CG. Disorders of hemostasis. In: Nelson RW, Couto CG, editors. 4th ed.
Missouri: Mosby Elsevier; 2009. p. 1242–1259
9. Kohn B, Weingart C, Giger U. Haemorrhage in seven cats with suspected
The authors would like to thank Ellen Belknap, DVM, MS, anticoagulant rodenticide intoxication. J Feline Med Surg 5:295–304, 2003
DACVIM (large animal), DACVO, and Andrew Mackin, BSc, BVMS, 10. Hornfeldt CS, Murphy MJ. Summary of small animal poison exposures in a
MVS, DVSc, FANZCVSc, DACVIM, for donations of photographs. major metropolitan area. In: Bonagura JD, editor. Philadelphia: WB Saunders;
1999. p. 205
11. Peterson JL, Couto CG, Wellman ML. Hemostatic disorders in cats: a retro-
spective study and review of the literature. J Vet Intern Med 9:298–303, 1995
References 12. Shelah-Goraly M, Aroch I, Kass PH, Bruchim Y, Ofri R. A prospective study of the
association of anemia and thrombocytopenia with ocular lesions in dogs. Vet J
182:187–192, 2008
1. Hendrix DVH. Diseases and surgery of the canine anterior uvea. In: Gelatt KN,
13. Putsche JC, Kohn B. Primary immune-mediate thrombocytopenia in 30 dogs
Gilger BC, Kern TJ, editors. 5th ed. Oxford: Wiley-Blackwell; 2013. p. 1146–1198
(1997-2003). J Am Animal Hosp Assoc 44:250–257, 2008
2. Nelson RW, Couto CG, editors. Disorders of hemostasis. Small Animal Internal
14. Carraro MC, Rossetti L, Gerli GC. Prevalence of retinopathy in patients with
Medicine. 4th ed. Missouri: Mosby Elsevier; 2009. p. 1242–1259
3. Nelms SR, Nasisse MP, Davidson MG, Kirschner SE. Hyphema associated with anemia or thrombocytopenia. Eur J Haematol 67:238–244, 2001
retinal disease in dogs: 17 cases (1986-1991). J Am Vet Med Assoc 15. Wilcock BP, Peiffer Jr RL. Morphology and behavior of primary ocular
202:1289–1292, 1993 melanomas in 91 dogs. Vet Pathol 23:418–424, 1986
4. Mitchell N. Ophthalmology: hyphaema in dogs. Compan Anim 11:85–89, 2006 16. Yi N, Park S, Jeong M, et al. Malignant ocular melanoma in a dog. J Vet Sci
5. Komàromy AM, Ramsey DT, Brooks DE, Ramsey CC, Kallberg ME. Hyphema. 7:89–90, 2006
Part I. Pathophysiologic considerations. Compend Contin Educ Pract Vet 17. Couto CG. Lymphoma in the dog and cat. In: Nelson RW, Couto CG, editors.
21:1064–1069, 1999 4th ed. Missouri: Mosby Elsevier; 2009. p. 1174–1186
106 M.R. Telle, C. Betbeze / Topics in Companion An Med 30 (2015) 97–106
18. Zemann BI, Moore AS, Rand WM, et al. A combination chemotherapy 32. Maggio F, DeFrancesco TC, Atkins CE, Pizzirani S, Gilger BC, Davidson MG.
protocol (VELCAP-L) for dogs with lymphoma. J Vet Intern Med 12:465–470, Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-
1998 1998). J Am Vet Med Assoc 217:695–702, 2000
19. Krohne SG, Henderson NM, Richardson RC, Vestre WA. Prevalence of ocular 33. Kaste SC, Jenkins JJ, Meyer D, Fontanesi J, Pratt CB. Persistent hyperplastic
involvement in dogs with multicentric lymphoma: prospective evaluation of primary vitreous of the eye: imaging findings with pathologic correlation. Am J
94 cases. Vet Comp Ophthalmol 4:127–135, 1995 Radiol 162:437–440, 1994
20. Carlton WW, Austin L. Ocular protothecosis in a dog. Vet Pathol 10:274–280, 34. Ghazi NG, Green WR. Pathology and pathogenesis of retinal detachment. Eye
1973 16:411–421, 2002
21. Stenner VJ, Mackay B, King VR, et al. Protothecosis in 17 Australian dogs and a 35. Massa KL, Gilger BC, Miller TL, Davidson MG. Causes of uveitis in dogs: 102
review of the canine literature. Med Mycol 45:249–266, 2007 cases (1989-2000). Vet Ophthalmol 5:93–98, 2002
22. Schultz RM, Johnson EG, Wisner ER, Brown NA, Byrne BA, Sykes JE. Clinicopa- 36. Peiffer Jr RL, Wilcock BP, Yin H. The pathogenesis and significance of pre-iridal
thologic and diagnostic imaging characteristics of systemic aspergillosis in 30 fibrovascular membranes in domestic animals. Vet Pathol 27:41–45, 1990
dogs. J Vet Intern Med 22:851–859, 2008 37. Komàromy AM, Ramsey DT, Brooks DE, Ramsey CC, Kallberg ME. Hyphema.
23. Leiva M, Naranjo C, Pena MT. Ocular signs of canine monocytic ehrlichiosis: a Part II. Diagnosis and treatment. Compend Contin Educ Pract Vet 22:74–79, 2000
38. Trepanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides
retrospective study in dogs from Barcelona, Spain. Vet Ophthalmol 8:387–393,
in the dog. J Vet Pharmacol Therap 27:129–138, 2004
2005
39. Ginn JA, Bentley E, Stepien RL. Systemic hypertension and hypertensive
24. Harrus S, Ofri R, Aizenberg I, Waner T. Acute blindness associated with
retinopathy following PPA overdose in a dog. J Am Anim Hosp Assoc 49:46–53,
monoclonal gammopathy induced by Ehrlichia canis infection. Vet Parasitol
2013
78:155–160, 1998
40. Hackner SG. Approach to the diagnosis of bleeding disorders. Compend Contin
25. Frank JR, Breitschwerdt EB. A retrospective study of ehrlichiosis in 62 dogs
Educ Pract Vet 17:331–349, 1995
from North Carolina and Virginia. J Vet Intern Med 13:194–201, 1999
41. Cook AK, Nelson WR. Feline infectious peritonitis: strategies for diagnosis and
26. Vinayak A, Green CE, Moore PA, Powell-Johnson G. Clinical resolution of
treating this deadly disease in young cats. Vet Med:430–437, 2013
Brucella canis-induced ocular inflammation in a dog. J Am Vet Med Assoc 42. Chavkin MJ, Lappin MR, Powell CC, Roberts SM, Parshall CJ, Reif JS. Seroepide-
224:1804–1807, 2004 miologic and clinical observations of 93 cases of uveitis in cats. Prog Vet Comp
27. Hollett RB. Canine brucellosis: outbreaks and compliance. Theriogenology Ophthalmol 2:29–36, 1992
66:575–587, 2006 43. Koch SA. Hyphema caused by an intraoral foreign body in a dog. J Am Vet Med
28. Davidson MG, Breitschwerdt EB, Nasisse MP, Roberts SM. Ocular manifesta- Assoc 162:123–124, 1973
tions of Rocky Mountain spotted fever in dogs. J Am Vet Med Assoc 44. Walton W, Von Hagen S, Grigorian R, Zarbin M. Management of traumatic
194:777–781, 1989 hyphema. Surv Ophthalmol 47:297–334, 2002
29. Warner RD, Marsh WW. Rocky Mountain spotted fever. J Am Vet Med Assoc 45. Gerding PA, Essex-Sorlie D, Vasaune S, Yack R. Use of tissue plasminogen
221:1413–1417, 2002 activator for intraocular fibrinolysis in dogs. Am J Vet Res 53:894–896, 1992
30. Ware WA. Systemic arterial hypertension. In: Nelson RW, Couto CG, editors. 46. Martin C, Kaswan R, Gratzek A, Champagne E, Salisbury MA, Ward D. Ocular
4th ed. Missouri: Mosby Elsevier; 2009. p. 184–191 use of tissue plasminogen activator in companion animals. Prog Vet Comp
31. LeBlanc NL, Stepien RL, Bentley E. Ocular lesions associated with systemic Ophthalmol 3:29–36, 1993
hypertension in dogs: 65 cases (2005-2007). J Am Vet Med Assoc 238:915–921, 47. Watkins G, Venable HP. E-aminocaproic acid in traumatic hyphema. J Natl Med
2011 Assoc:484–486, 1974